Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy
- 20 May 2015
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 7 (288) , 288ra76
Abstract
Targeting joint-lining fibroblast-like synoviocytes reduces the severity of arthritis.Keywords
Funding Information
- NIH (AR066053, AR47825, AI070555, UL1TR000100, AR064202)
- Juvenile Diabetes Research Foundation
- Canadian Institutes for Health Research Fellowship
This publication has 45 references indexed in Scilit:
- NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycansNature Neuroscience, 2012
- Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cellsBMC Cancer, 2012
- Cadherin-11 regulates fibroblast inflammationProceedings of the National Academy of Sciences, 2011
- Proteoglycan-Specific Molecular Switch for RPTPσ Clustering and Neuronal ExtensionScience, 2011
- Caspase 1–independent activation of interleukin‐1β in neutrophil‐predominant inflammationArthritis & Rheumatism, 2009
- PTPσ Is a Receptor for Chondroitin Sulfate Proteoglycan, an Inhibitor of Neural RegenerationScience, 2009
- Maturation of ureter-bladder connection in mice is controlled by LAR family receptor protein tyrosine phosphatasesJournal of Clinical Investigation, 2009
- Cells of the synovium in rheumatoid arthritis. Synovial fibroblastsArthritis Research & Therapy, 2007
- N-Cadherin Is an In Vivo Substrate for Protein Tyrosine Phosphatase Sigma (PTPσ) and Participates in PTPσ-Mediated Inhibition of Axon GrowthMolecular and Cellular Biology, 2007
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988